ATEX · Anterix Inc.

Current Thesis

The re-rating leg has largely been paid. Anterix monetizes licensed 900 MHz spectrum (contiguous US plus HI/AK/PR) by selling it to utilities for private LTE/5G "super-pipe" networks via its CatalyX platform. The narrative that moved the stock was regulatory: on 2026-02-18 the FCC unanimously adopted the Report & Order expanding the 900 MHz broadband segment from 6 MHz to a 10 MHz (5x5) configuration. Management framed that as lifting implied spectrum value to roughly $2.5B–$7B+ (from ~$1.5B–$4B at 6 MHz). That single rule drove a ~3.7x advance off the $17.58 52-week low to the $67.19 high. As of 2026-06-01 the stock sat at $66.24, ~1% under that high, market cap ~$1.24B. The theme is now MATURING, not accelerating: sell-side is catching up (B. Riley cut to Neutral on 2026-06-04 with PT $69 ≈ spot), and Q4 FY2026 results drop after close 2026-06-10 a binary print into a fully extended tape three trading days out.

Bull Case

• Spectrum value step-change banked, not yet fully monetized. FCC final rule (2026-02-18) doubled the addressable value range to ~$2.5B–$7B+; current market cap ~$1.24B sits at the low end of that implied range, leaving headroom if contracting accelerates.
• Contracted-proceeds visibility. Q3 FY2026 (reported 2026-02-11) showed ~$123M contracted proceeds outstanding with line of sight to collect $80M+ in Q4 FY2026 a near-term cash catalyst tied to the 2026-06-10 print.
• Pipeline depth. ~$400M in signed contracts, ~$3B prospective pipeline, ~$500M sitting in Phase 3 (late-stage). Recent signings: Texas-New Mexico Power and NorthWestern Energy, both post-FCC-order evidence the rule is converting to deals.
• Turn to profitability. Next-quarter EPS estimate ~$0.98 vs Q3 FY2026 actual -$0.41 (which beat -$0.55) a profitability inflection the print could confirm.
• Optionality. FCC approval (2026-05-18) for Anterix/Lynk Global to explore satellite direct-to-device on the 900 MHz band adds a second monetization avenue beyond terrestrial utility deals.
• Clean balance sheet + buyback dry powder. $29.5M cash, no debt at 2025-12-31; $226.7M remaining under the $250M repurchase authorization (through 2026-09-21).

Bear Case

• Easy money already made. The Feb re-rating is ~4 months in the rearview; buying at $66 is buying ~1% off the all-time high after a 3.7x, not catching a fresh leg.
• Sell-side now neutral. B. Riley downgrade to Neutral (2026-06-04, PT $69) caps perceived upside at ~spot; a separate target as low as $50 implies real downside if signings disappoint.
• Binary print in 3 trading days. Q4 FY2026 after close 2026-06-10 pre-profit spectrum names gap hard on guidance; a soft FY2027 signing outlook or sub-$80M proceeds collection re-rates lower.
• Thin cash, lumpy revenue. $29.5M cash and deal-by-deal proceeds make results lumpy; one slipped contract reshapes the quarter.
• No buyback support yet. Zero repurchases in Q3 FY2026 despite the authorization management is not defending the stock at these levels.

Setup & Price Structure

• Last ~$66.24 (2026-06-01); 52-week range $17.58–$67.19, so price is pinned to the top of the range, deeply extended above all rising MAs after the 3.7x move.
• The base that matters is the post-FCC consolidation built since the 2026-02-18 order; the breakout shelf sits roughly $54–55. A daily close back below that is the structural thesis-break.
• Analyst PTs bracket the tape: B. Riley $69 (Neutral, 2026-06-04) above, a $50 target below limited reward, real downside if the print misses.
• This is a stretched-into-binary setup, not a clean ACCELERATING entry: at the 52-week high, with sell-side just downgraded, and earnings 3 trading days out. The disciplined read is to let the 2026-06-10 print clear before committing, then re-enter on a held higher-low only if guidance re-accelerates the signing cadence.

Catalyst Calendar (next 30 days)

• 2026-06-10 (after close): Q4 + full-year FY2026 results. Watch: collection of $80M+ of the $123M contracted proceeds, FY2027 contract-signing outlook, EPS vs ~$0.98 est, any buyback activation. Binary.
• 2026-06-11, 9:00am ET: Q4 FY2026 earnings conference call guidance/tone on Phase-3 (~$500M) conversion.
• Rolling (8-K driven): new utility spectrum-lease signings (post-TNMP/NorthWestern cadence); any single large deal is a step-function catalyst.
• Rolling: Lynk Global satellite D2D follow-on (post the 2026-05-18 FCC approval) commercialization detail would extend the narrative.

What Would Change Our Mind

• Re-accelerate (turn constructive): Q4 print collects $80M+ and guides FY2027 signings up; a new large utility contract converts Phase-3 pipeline; buyback finally activated. A held breakout above $67.19 on that news flips this back toward ACCELERATING.
• Break (stay out / exit): daily close below the post-FCC base (~$54); Q4 FY2026 collects <$80M of contracted proceeds or guides FY2027 signings lower; pipeline conversion stalls quarter-over-quarter. Any of these confirms the theme has rolled to SATURATED with the regulatory catalyst spent.

Correlation Notes

Anterix is idiosyncratic driven by FCC spectrum policy and utility grid-modernization capex, not broad semis, AI, or the prior auto-discovered "korea-asia-semi-beta" / "space-satellite" tags, which are spurious and should be dropped. Closest real correlations: critical-infrastructure / utility capex cycles and FCC-policy headlines. As a pre-profit, long-duration spectrum asset it carries rate sensitivity (re-rates on duration). The Lynk D2D approval introduces a thin satellite-direct-to-device thread, but terrestrial utility leasing remains the core driver. Effectively a single-name regulatory/event book no peer cluster to confirm or fade it.

Notes

Earnings blackout: avoid fresh exposure into the 2026-06-10 after-close print. Buyback authorization ($226.7M remaining) expires 2026-09-21 watch for activation as a sentiment tell.

Themes

private-wireless-spectrum, utility-grid-modernization, fcc-spectrum-catalyst, satellite-d2d-optionality